Number of the records: 1

interferón beta-1b

SYS		d000068576
LBL		00000nz--a2200181n--4500
005		20250606221736.5
008		160101\|\|\|anznnbabn-----------\|-a\|a------
040		$b slo $a BA006 $d BA006
065		$a D12.644.276.374.440.890.275.750
065		$a D12.776.467.374.440.890.275.750
065		$a D23.529.374.440.890.275.750
066		$a 01 $c 03
150		$a interferón beta-1b $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo
450		$w v $a interferón beta 1b $2 slo
450		$w v $a beta-IFN-1b $2 slo
450		$w v $a IFN-beta ser $2 slo
550		$7 sllk_us_auth*d000276 $Y Adjuvants, Immunologic $w P $a adjuvanciá imunologické
665		$a 2016 (1985) $2 eng
680	9-	$i A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS. $2 eng
750	-2	$a Interferon beta-1b $2 eng
980		$x M

Number of the records: 1